Stay updated on Efruxifermin in NASH Subjects Clinical Trial

Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added 'Non-alcoholic fatty liver disease' to the MedlinePlus Genetics related topics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-26T16:29:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing site locations across Arizona, Arkansas, California, Florida, Louisiana, Missouri, New Jersey, Tennessee, and Texas and updated the revision to v3.3.3; removed the prior separate state-location entries and some related topics (MedlinePlus Genetics, Non-alcoholic fatty liver disease, HHS Vulnerability Disclosure).
    Difference
    1%
    Check dated 2025-12-19T12:28:50.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added related topics links for Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-05T02:36:58.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    MeSH term 'Non-alcoholic fatty liver disease' and related topics such as 'MedlinePlus Genetics' were removed. A new 'Revision: v3.3.2' tag was added, replacing the previous 'Revision: v3.3.1', To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-28T01:17:54.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added related topics including Non-alcoholic fatty liver disease and PubMed-based notes (MedlinePlus Genetics) and included revision tag v3.3.1. Removed the generic PubMed disclaimer; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-20T22:18:45.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The government funding/operating status banner on the page was removed. The study details, eligibility criteria, and locations remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-13T15:57:21.000Z thumbnail image

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.